COMMUNIQUÉS West-GlobeNewswire

ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies

10/10/2017 - 08:52

Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of warrants out of a total [...]

Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO)

10/10/2017 - 08:30

Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO) Lugano, Switzerland, [...]

Solon Eiendom ASA : Primary insider notification

10/10/2017 - 08:30

(Oslo, Norway, 09 October 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 18,306 shares in Solon Eiendom ASA at a price of NOK 18.7198 per [...]

Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC

10/10/2017 - 08:00

Press Release 10 October 2017 Immunicum AB (publ) Announces Appointment of Sharon Longhurst as Head of CMC Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming [...]

Akcea Therapeutics' Volanesorsen Receives Promising Innovative Medicine (PIM) Status for the Treatment of Familial Chylomicronaemia Syndrome (FCS)

10/10/2017 - 08:00

LONDON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics United Kingdom (UK) today announced that volanesorsen has been granted a Promising Innovative Medicine (PIM) Designation by the Medicines and Healthcare [...]

Nicox et pSivida : accord de collaboration stratégique en vue du développement d'un médicament à libération prolongée pour réduire la pression intraoculaire chez les patients atteints de glaucome

10/10/2017 - 07:30

Communiqué de presse Nicox et pSivida : accord de collaboration stratégique en vue du développement d'un médicament à libération prolongée pour réduire la pression intraoculaire chez les patients atteints de glaucome [...]

Nicox and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular pressure in patients with glaucoma

10/10/2017 - 07:30

Press Release Nicox and pSivida Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in Patients with Glaucoma Focus will be on Combining Nicox's New Nitric Oxide [...]

MITHRA'S MARKETING AUTHORIZATION APPLICATION FOR TIBELIA® ACCEPTED BY HEALTH CANADA

10/10/2017 - 07:30

PRESS RELEASE MIThRA'S MARKETING AUTHORIZATION APPLICATION FOR TiBELIA® ACCEPTED BY HEALTH CANADA Tibelia® would be the first tibolone-based Hormone Therapy product available in Canada Marketing Authorization (MA) [...]

ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies

10/10/2017 - 07:17

Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of warrants out of a total [...]

Biocartis Group NV: Disclosure of outstanding voting securities

10/10/2017 - 07:00

PRESS RELEASE: REGULATED INFORMATION 10 October 2017, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 10 October 2017 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]

Medtronic to Establish Innovation Center in Chengdu

10/10/2017 - 07:00

Facilitating Clinical Training for Physicians and Advancing Local Healthcare Efficiency in Central and Western China DUBLIN and CHENGDU, Sichuan - October 10, 2017 - Medtronic plc (NYSE:MDT) today announced the [...]

IBA SA : IBA signe un accord de collaboration mondial avec VINCI Construction

10/10/2017 - 07:00

IBA signe un accord de collaboration mondial avec VINCI Construction Nouvelle collaboration afin de fournir un soutien de conception et de construction de centres de protonthérapie spécifiquement destiné aux clients d' [...]

IBA SA : IBA signs global construction collaboration with VINCI Construction

10/10/2017 - 07:00

IBA signs global construction collaboration with VINCI Construction New collaboration to provide dedicated proton therapy center design and construction support for customers Louvain-La-Neuve, Belgium, 10 October 2017 [...]

Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team

09/10/2017 - 20:30

Press release 2017-10-09 Xbrane Biopharma AB (publ) has appointed Dina Jurman, Head of Clinical Affairs at Xbrane, to its management team. Dina holds a M.Sc. in Biomedicine from Uppsala University and has previously [...]

CORRECTION: Össur hf: Q3 2017 Results - Conference call Wednesday 25 October at 9:00 CET

09/10/2017 - 18:41

This is a correction of the announcement from 16:15 09.10.2017 GMT. Reason for the correction: Changes made to the Icelandic version. No change to the English version. Announcement from Össur hf. no: 72/2017 Conference [...]

Össur hf: Q3 2017 Results - Conference call Wednesday 25 October at 9:00 CET

09/10/2017 - 18:15

Announcement from Össur hf. no: 72/2017 Conference call on Wednesday 25 October at 9:00 CET / 7:00 GMT / 3:00 EDT After market closing on Tuesday 24 October, Össur will publish its financial results for Q3 2017. On [...]

Ossur Hf : Transactions in relation to share buyback program

09/10/2017 - 18:00

Announcement from Össur hf. No. 71/2017 Reykjavík, 9 October 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Terveystalo Plc announces the early close of the Institutional Offering due to oversubscription

09/10/2017 - 17:00

TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 9, 2017 at 6:00 pm NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]

Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA

09/10/2017 - 15:08

Oslo, Norway, 9 October 2017 The Board of Directors of Vistin Pharma ASA has decided to propose for an extraordinary general meeting an interim dividend of NOK 7.00 per share. Dividend amount: 7.00 per share Declared [...]